Tianhua Ma
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Dual-targeting pharmacological UFMylation inhibition reprograms tumor and immune microenvironments to achieve long-term glioblastoma regression.
Journal: Signal transduction and targeted therapy
Published: July 23, 2025
ALDOA-Mediated Metabolic Reprogramming is a Targetable Vulnerability for Ferroptosis Sensitization in Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 28, 2025
Minimizing far-extending chromatin perturbation in genome editing preserves stem cell identity.
Journal: Cell stem cell
Published: December 10, 2024
Pharmacologically inducing regenerative cardiac cells by small molecule drugs.
Journal: eLife
Published: December 09, 2024
Extended pegRNAs enhance the editing capability of Prime editing.
Journal: Trends in biotechnology
Published: March 22, 2024
The transcription factor MEF2C restrains microglial overactivation by inhibiting kinase CDK2.
Journal: Immunity
Published: November 29, 2023
Dual-role transcription factors stabilize intermediate expression levels.
Journal: Cell
Published: June 09, 2023
KDM4 inhibitor SD49-7 attenuates leukemia stem cell via KDM4A/MDM2/p21CIP1 axis.
Journal: Theranostics
Published: January 26, 2022
Induction of mouse totipotent stem cells by a defined chemical cocktail.
Journal: Nature
Published: August 24, 2021
Non-viral approaches for somatic cell reprogramming into cardiomyocytes.
Journal: Seminars in cell & developmental biology
Published: March 23, 2021
Last Updated: 09/26/2026